Page last updated: 2024-11-04

sulfasalazine and Atypical Mycobacterial Infection, Disseminated

sulfasalazine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Clarithromycin was continued a further two months until the patient quit on her own and."1.36[A cutaneous infection by Mycobacterium chelonae in a patient with rheumatoid arthritis]. ( Azevedo, F; Baudrier, T; Duarte, AF; Ferreira, O; Mota, A; Simões, JS, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferreira, O1
Duarte, AF1
Baudrier, T1
Mota, A1
Simões, JS1
Azevedo, F1

Other Studies

1 other study available for sulfasalazine and Atypical Mycobacterial Infection, Disseminated

ArticleYear
[A cutaneous infection by Mycobacterium chelonae in a patient with rheumatoid arthritis].
    Dermatology online journal, 2010, Apr-15, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Combinations; Fema

2010